More on CATX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+31.4% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Perspective Therapeutics (NY:CATX)
Delayed: 2.77 -0.22 (7.36%)
Prev. Close $2.99  
Open$2.96 
52 Wk High$ 
52 Wk Low$ 
Day High$3.01 
Day Low$2.75 
P/E N/A  
EPS$ 
Volume1,582,608 

Friends, Peers and Foes (?): IDYA, ACAD, BCRX, CDTX, CRBP (more...)

Sep 8, 2026 05:17 PM Form 8-K Perspective Therapeutics For: Sep 08
Sep 8, 2026 04:51 PM Form 4 Perspective Therapeutics For: Sep 03 Filed by: Lantheus Holdings, Inc.
Sep 4, 2026 05:01 PM Form 4 Perspective Therapeutics For: Sep 02 Filed by: Lantheus Holdings, Inc.
Sep 4, 2026 04:59 PM Form 4 Perspective Therapeutics For: Aug 31 Filed by: Lantheus Alpha Therapy, LLC
Sep 4, 2026 04:49 PM Form SCHEDULE 13D/A Perspective Therapeutics Filed by: Lantheus Holdings, Inc.
Sep 3, 2026 04:55 PM Form 4 Perspective Therapeutics For: Sep 01 Filed by: Lantheus Holdings, Inc.
Sep 2, 2026 04:36 PM Form 4 Perspective Therapeutics For: Aug 31 Filed by: Lantheus Holdings, Inc.
Aug 18, 2026 04:13 PM BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
Aug 14, 2026 05:18 AM Perspective Therapeutics Inc (CATX) PT Lowered to $5 at BofA Securities
Aug 13, 2026 07:59 PM Form SCHEDULE 13G/A Perspective Therapeutics Filed by: MILLENNIUM MANAGEMENT LLC
View All Articles

Entities mentioned with CATX

View All Entities